These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 542112)
1. [Determination of relative drug efficacy in dermatological skin preparations]. Proppe A; Penner K Med Welt; 1979 Dec; 30(51-52):1938-40. PubMed ID: 542112 [No Abstract] [Full Text] [Related]
2. [Therapeutic action of the topical use of 2 new dermatological preparations]. Charro Martínez L Actas Dermosifiliogr; 1976; 67(7-8):599-606. PubMed ID: 785972 [No Abstract] [Full Text] [Related]
3. [Triamcinolone acetonide as local therapeutic agent in inflammatory dermatoses]. Brun F; Küng D Schweiz Rundsch Med Prax; 1972 Jul; 61(30):977-9. PubMed ID: 4564727 [No Abstract] [Full Text] [Related]
4. Corticosteroid creams: relative efficacy in common dermatological disorders. Fishman HC West Med Med J West; 1965 Oct; 6(10):270-1. PubMed ID: 5319763 [No Abstract] [Full Text] [Related]
5. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis. Schuttelaar ML; Coenraads PJ J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1076-82. PubMed ID: 18384552 [TBL] [Abstract][Full Text] [Related]
6. [Atrophic cutaneous straie localized in an area of prolonged application of corticosteroid ointment]. Cainelli T G Ital Dermatol Minerva Dermatol; 1966; 107(2):129-34. PubMed ID: 6012802 [No Abstract] [Full Text] [Related]
7. Fenticlor combined with triamcinolone acetonide in the treatment of infected dermatoses. Ashurst PJ Br J Clin Pract; 1972 Sep; 26(9):409-12. PubMed ID: 4562672 [No Abstract] [Full Text] [Related]
9. [Therapeutic value of Polcortolon aerosol Polfa in skin diseases]. Prochacki H; Adamska M; Korobiec M Przegl Dermatol; 1972; 59(5):635-40. PubMed ID: 4637737 [No Abstract] [Full Text] [Related]
10. [Clinical evaluation of dermatologic external preparations. II. External preparations with corticoids. 1. Influence of triamcinolon acetonide concentration on therapeutic effect (author's transl)]. Melichar M; Viktorinová M; Hýblová R Cesk Dermatol; 1979 Apr; 54(2):73-8. PubMed ID: 427887 [No Abstract] [Full Text] [Related]
11. [A topical combination of triamcinolone acetonide 0.1% + econazole nitrate 1% in cream, ointment and fatty ointment. A multicentre study on eczema]. Schwarz KJ; Konzelmann M Schweiz Rundsch Med Prax; 1982 Apr; 71(14):606-11. PubMed ID: 7045859 [No Abstract] [Full Text] [Related]
12. [Monacort aerosol Polfa in the treatment of skin diseases]. Szarmach H; Poniecka H; Jakubowski A Przegl Dermatol; 1972; 59(5):641-6. PubMed ID: 4637738 [No Abstract] [Full Text] [Related]
13. [Use of Flogosam and Fluorocort ointments in dermatological practice]. Kapkaev RA; Abaliants LA Vestn Dermatol Venerol; 1972 Sep; 46(9):68-9. PubMed ID: 4568752 [No Abstract] [Full Text] [Related]
14. Are generic formulations equivalent to trade name topical glucocorticoids? Stoughton RB Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%. Oldhoff JM; Knol EF; Laaper-Ertmann M; Bruijnzeel-Koomen CA; de Bruin-Weller MS Allergy; 2006 May; 61(5):622-8. PubMed ID: 16629794 [TBL] [Abstract][Full Text] [Related]
16. [On the dermatological use of a fluocinolone acetonide ointment, with special reference to topical therapy of psoriasis]. Zar E Minerva Med; 1971 Apr; 62(27):1418-27. PubMed ID: 5553842 [No Abstract] [Full Text] [Related]
17. [Evaluation of the efficiency of corticosteroid preparations in the treatment of psoriasis]. Montero ED Med Cutan Ibero Lat Am; 1976; 4(3):195-7. PubMed ID: 988458 [TBL] [Abstract][Full Text] [Related]
18. Selection of the acceptor medium in in vitro measurements of drug release from dermatological ointments. Gloor M; Shabafrouz H Dermatologica; 1983; 166(2):69-74. PubMed ID: 6852320 [TBL] [Abstract][Full Text] [Related]